Crossmark

Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors

Crossref DOI link: https://doi.org/10.1007/s00774-015-0699-6

Published Online: 2015-07-25

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bahtiri, Elton

Islami, Hilmi

Hoxha, Rexhep

Qorraj-Bytyqi, Hasime

Rexhepi, Sylejman

Hoti, Kreshnik

Thaçi, Kujtim

Thaçi, Shpetim

Karakulak, Çağla
Funding

Funding for this research was provided by:

Ministry of Education, Science and Technology (MEST) of Republic of Kosova (2-4447)
License Information

Text and Data Mining valid from 2015-07-25

Document is current

Any future updates will be listed below